Realising the right to sexual and reproductive health: access to essential medicines for medical abortion as a core obligation
OPEN BMC international health and human rights | 3 Feb 2018
K Perehudoff, L Berro Pizzarossa and J Stekelenburg
WHO has a pivotal role to play as the leading international agency promoting good practices in health and human rights. In 2005, mifepristone and misoprostol were added to WHO’s Model List of Essential Medicines for combined use to terminate unwanted pregnancies. However, these drugs were considered ‘complementary’ and qualified for use when in line with national legislation and where ‘culturally acceptable’.
* Data courtesy of Altmetric.com